COVID-19 Pandemic: India’s Journey from Crisis to Resilience and Innovation

Authors

DOI:

https://doi.org/10.56450/JEFI.2026.v4i03.002

Keywords:

Vaccine development, Diagnostics, COVID-19, Digital tools

Abstract

The COVID-19 pandemic exposed gaps in India’s preparedness for a public health emergency, including limited laboratory capacity, dependence on imported diagnostics and personal protective equipment (PPE), constrained healthcare surge capacity, and the absence of an established COVID-19 vaccine development programme. However, the crisis catalysed transformation of India’s health security capabilities. Through mobilisation of government, scientists, healthcare workers, academia and industry, India expanded its molecular testing network from fewer than 300 laboratories to approximately 3,300, strengthened quality assurance, and established indigenous diagnostic manufacturing capacity. Repurposing existing platforms, including TrueNat, and standardised validation frameworks enabled access to affordable diagnostics and created infrastructure for multipathogen testing.

India simultaneously developed a PPE ecosystem, progressing from negligible production to more than 1,100 manufacturers and capacity exceeding 10 lakh coveralls per day by the end of 2020. Vaccine development was accelerated through established platforms, parallelisation of development activities, public–private partnerships, and Mission COVID Suraksha. This enabled development and deployment of multiple vaccines, including COVAXIN, while strengthening clinical, regulatory and manufacturing infrastructure. Vaccine Maitri demonstrated India’s capacity to combine manufacturing with global health responsibility.

The pandemic drove expansion of hospital and critical-care capacity, medical oxygen production, workforce training, digital health infrastructure and large-scale immunisation systems, including Co-WIN. Collectively, these investments transformed India’s health security architecture. The experience established reusable laboratory, manufacturing, vaccine, regulatory, digital and workforce capabilities that can be rapidly mobilised for emerging and re-emerging infectious diseases. Sustaining these capacities will be critical to strengthening India’s future pandemic preparedness and contribution to global health security.

Downloads

Download data is not yet available.

References

1. Chetterje P. Gaps in India's preparedness for COVID-19 control. Lancet Infect Dis. 2020 May;20(5):544. doi: 10.1016/S1473-3099(20)30300-5. DOI: https://doi.org/10.1016/S1473-3099(20)30300-5

2. Gupta N, Potdar V, Praharaj I, et al. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. Indian J Med Res. 2020 Feb & Mar;151(2 & 3):216-225. doi: 10.4103/ijmr.IJMR_594_20. DOI: https://doi.org/10.4103/ijmr.IJMR_594_20

3. Gupta N, Bhatnagar T, Rade K, Murhekar M, Gangakhedkar RR, Nagar A; ICMR COVID Team. Strategic planning to augment the testing capacity for COVID-19 in India. Indian J Med Res. 2020 Feb & Mar;151(2 & 3):210-215. doi: 10.4103/ijmr.IJMR_1166_20. DOI: https://doi.org/10.4103/ijmr.IJMR_1166_20

4. Press Information Bureau; Government of India; Ministry of Health and Family Welfare. COVID-19 Update: Availability of PPE kits, N95 masks and ventilators. 30 March 2020. https://www.pib.gov.in/PressReleasePage.aspx.

5. Medical Council of India. Inclusion of BSL-2 level laboratory testing facility for infectious pathogens in the Department of Microbiology in all Medical Colleges by amending the Minimum Standard Requirements for 50/100/150/200/250 MBBS Admissions Annually Regulations. June 16, 2020. https://medicaldialogues.in/pdf_upload/pdf_upload-130524.pdf.

6. Kaur H, Mukhopadhyay L, Gupta N, Aggarwal N, Sangal L, Potdar V, et al. (2022). External quality assessment of COVID-19 real timereverse transcription PCR laboratories in India. PLoS ONE 17(2): e0263736. https://doi.org/10.1371/journal.pone.0263736 DOI: https://doi.org/10.1371/journal.pone.0263736

7. https://www.who.int/india/news-room/feature-stories/detail/how-india-scaled-up-its-laboratory-testing-capacity-for-covid19? 16 August 2020.

8. Gupta N, Rana S, Singh H. Innovative point-of-care molecular diagnostic test for COVID-19 in India. Lancet Microbe. 2020 Nov;1(7):e277. doi: 10.1016/S2666-5247(20)30164-6. DOI: https://doi.org/10.1016/S2666-5247(20)30164-6

9. https://www.icmr.gov.in/icmrobject/uploads/Static/1767866918_listofapprovedkitsfortb_08012026.pdf.

10. Press Information Bureau; Government of India; Ministry of Science & Technology. Technology based startups played a crucial role in converting India from importer to second largest manufacturer of PPEs. 31 December 2020.

11. Press Information Bureau; Government of India; Ministry of Textiles. Year End Review 2020.18 September 2020. https://www.pib.gov.in/Pressreleaseshare.aspx.

12. Ministry of Health and Family Welfare; How the Domestic Medical Equipment Industry “Adapted, Evolved and Expanded” to meet COVID19 challenge in 2020; 31 December 2020. https://www.pib.gov.in/PressReleasePage.aspx.

13. Press Information Bureau, Government of India, Ministry of Science & Technology. Union Minister Dr Jitendra Singh says, India has developed four indigenous Vaccines in just two years. 27 January 2023. https://www.pib.gov.in/Pressreleaseshare.aspx.

14. https://www.icmr.gov.in/icmrobject/custom_data/1702893111_icmr_press_release_04072020.pdf. ICMR process to develop vaccine to fight Covid 19 pandemic as per globally accepted norms of fast tracking;

15. Press Information Bureau; Government of India; Ministry of Health and Family Welfare. Export of Covid-19 Vaccines. 7 December 2021. https://www.pib.gov.in/PressReleasePage.aspx.

16. Press Information Bureau; Government of India; Ministry of Health and Family Welfare. High Level Committee for Distribution and Administration of COVID-19 Vaccines. 2 February 2021. https://www.pib.gov.in/Pressreleaseshare.aspx.

17. Ministry of Health and Family Welfare, Government of India. S.O. 1511(E): Regulations for manufacture and stock of vaccines for COVID-19. 18 May 2020. https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadGazette_Notifications.

18. Press Information Bureau; Government of India; Ministry of Finance. National COVID-19 vaccination programme meets its goals by overcoming R&D and logistical challenges, says Economic survey 2022-23. 31 Jan 2023. https://www.pib.gov.in/pressreleasepage.aspx.

19. Press Information Bureau, Government of India, Ministry of AYUSH. National Clinical Management Protocol based on Ayurveda and Yoga for management of COVID-19. 2020. 06 October 2020. https://www.pib.gov.in/PressReleasePage.aspx.

20. Press Information Bureau, Government of India. Prime Minister’s Office. PM chairs high-level meeting to review COVID-19 related situation; PM reviews availability of medical infrastructure. 27 April 2021. https://www.pib.gov.in/PressReleasePage.aspx.

21. Press Information Bureau, Government of India, Department of Commerce, Government of India. Major Highlights of the Department of Commerce during 2020. 30 December 2020. https://www.pib.gov.in/newsite/erelcontent.aspx.

22. Press Information Bureau, Government of India, Ministry of Health and Family Welfare. Setting up of COVID Hospitals. 23 September 2020. https://www.pib.gov.in/PressReleasePage.aspx.

23. Press Information Bureau, Government of India, Ministry of Health & Family Welfare. More than Half a Crore patients served by the National Telemedicine Service (eSanjeevani) during the COVID-19 Pandemic. 13 May 2021. https://www.pib.gov.in/Pressreleaseshare.aspx.

24. Press Information Bureau, Government of India, Ministry of Health & Family Welfare. eSanjeevani telemedicine service records 3 crore tele-consultations. 25 March 2022. https://www.pib.gov.in/Pressreleaseshare.aspx.

Downloads

Published

2026-09-30


How to Cite

1.
Gupta N. COVID-19 Pandemic: India’s Journey from Crisis to Resilience and Innovation. J. Epidemiol. Found. India [Internet]. 2026 Sep. 30 [cited 2026 Nov. 18];4(3):209-16. Available from: https://efi.org.in/journal/index.php/JEFI/article/view/653

Similar Articles

1-10 of 110

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)